arginine vasopressin has been researched along with Endotoxin Shock in 92 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (5.43) | 18.7374 |
1990's | 5 (5.43) | 18.2507 |
2000's | 43 (46.74) | 29.6817 |
2010's | 36 (39.13) | 24.3611 |
2020's | 3 (3.26) | 2.80 |
Authors | Studies |
---|---|
Duan, C; He, J; Kuang, L; Li, B; Li, T; Liu, L; Peng, X; Wu, Y; Yang, G; Zhang, J; Zhang, Z; Zhao, H; Zheng, D; Zhu, Y | 1 |
Jeon, K; Lee, J; Park, HK; Song, JU; Suh, GY | 1 |
Ammar, MA; Der-Nigoghossian, C; Hammond, DA | 1 |
Bauer, SR; Duggal, A; Lam, SW; Reddy, AJ; Sacha, GL | 1 |
Li, D; Wang, C; Yang, X; Zhang, Z; Zhou, Q | 1 |
Anger, KE; DeGrado, JR; Reardon, DP; Szumita, PM | 1 |
Lone, NA; Oba, Y | 1 |
Bakker, J; Wagener, G | 1 |
Chen, XM; Li, T; Liu, L; Xiao, X; Yue, W; Zhen, D; Zhu, Y | 1 |
Bissell, BD; Erdman, MJ; Ferreira, JA; Kraemer, DF; Smotherman, C | 1 |
He, X; Kjølbye, AL; Laporte, R; Moussa, MD; Reinheimer, TM; Su, F; Taccone, FS; Vincent, JL; Xie, K; Zhang, J | 1 |
Carr, AC; Fowler, AA; Natarajan, R; Shaw, GM | 1 |
Asfar, P; Radermacher, P; Russell, JA; Tuckermann, J | 1 |
Angelini, GD; Belletti, A; Benedetto, U; Biondi-Zoccai, G; Landoni, G; Leggieri, C; Silvani, P; Zangrillo, A | 1 |
Russell, JA | 3 |
Ertmer, C; Westphal, M | 1 |
Holmes, CL; Walley, KR | 1 |
Singer, M | 1 |
Bauer, SR; Cha, SS; Lam, SW; Oyen, LJ | 2 |
Branco, LG; Oliveira-Pelegrin, GR; Ravanelli, MI; Rocha, MJ | 1 |
Dörler, J; Dünser, MW; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Morgenthaler, NG; Ulmer, H; Wenzel, V | 1 |
Maybauer, DM; Maybauer, MO; Traber, DL | 1 |
Dünser, MW; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Torgersen, C; Wenzel, V | 1 |
Ertmer, C; Köhler, G; Lange, M; Moll, K; Morelli, A; Rehberg, S; Schlack, K; Spiegel, HU; Su, F; Van Aken, H; Vincent, JL; Westphal, M | 1 |
Meyer, S | 1 |
Asfar, P; Calzia, E; Georgieff, M; Giudici, R; Gröger, M; Hauser, B; Laporte, R; Möller, P; Ploner, F; Radermacher, P; Scheuerle, A; Simon, F; Vogt, JA; Wachter, U | 1 |
Enkhbaatar, P; Rehberg, S; Traber, DL | 1 |
Annane, D; Barrett, L; Blanchard, A; Brouland, JP; de la Grandmaison, GL; Gray, F; Guidoux, C; Mattot, V; Polito, A; Sharshar, T; Siami, S; Singer, M; Sonneville, R; Viltart, O | 1 |
Maybauer, MO; Walley, KR | 1 |
Annane, D; Bailly-Salin, J; Blanchard, A; Boucly, C; Carlier, R; Haymann, JP; Laborde, K; Maxime, V; Polito, A; Porcher, R; Sharshar, T; Siami, S | 1 |
Erren, M; Ertmer, C; Köhler, G; Lange, M; Morelli, A; Rehberg, S; Seisel, J; Spiegel, HU; Su, F; Traber, DL; Van Aken, H; Vincent, JL; Westphal, M | 1 |
Adrario, E; Donati, A; Pelaia, P; Preiser, JC | 1 |
Christ-Crain, M; Katan, M | 1 |
Bauer, SR; Lam, SW | 1 |
Ertmer, C; Lange, M; Morelli, A; Rehberg, S; Schneider, M; Traber, DL; Van Aken, H; Vincent, JL; Westphal, M | 1 |
Kampmeier, TG; Lange, M; Rehberg, S; Westphal, M | 1 |
Dünser, M; Ertmer, C; Kampmeier, TG; Lange, M; Lipke, E; Morelli, A; Rehberg, S; Strohhäcker, AK; Traber, DL; Van Aken, H; Westphal, M; Whorton, E | 1 |
Landry, DW; Oliver, JA | 1 |
Dünser, MW | 1 |
Gortner, L; Gottschling, S; McGuire, W; Meyer, S; Mohammed Shamdeen, G | 1 |
Maybauer, DM; Maybauer, MO | 1 |
Dünser, MW; Jochberger, S | 1 |
Ji, MH; Peng, YG; Wang, X; Yang, JJ | 1 |
Lauzier, F; Lesur, O | 1 |
Dünser, MW; Luckner, G; Rex, C; Schmittinger, CA; Schröder, DC; Torgersen, C; Ulmer, H | 1 |
Botticelli, L; D'Egidio, A; Di Russo, A; Donati, A; Ertmer, C; Kampmeier, T; Landoni, G; Lombrano, MR; Morelli, A; Orecchioni, A; Pietropaoli, P; Rehberg, S; Valentini, A; Westphal, M; Zangrillo, A | 1 |
Dong, L; Fan, Y; Ji, M; Li, GM; Li, R; Peng, YG; Wu, J; Yang, J | 1 |
Annane, D; Barrett, L; Brouland, JP; Chrétien, F; Gray, F; Guidoux, C; Lorin de la Grandmaison, G; Mattot, V; Polito, A; Sharshar, T; Siami, S; Singer, M; Sonneville, R; Viltart, O | 1 |
Cha, SS; Oyen, LJ; Personett, HA; Stollings, JL | 1 |
Enkhbaatar, P; Ferdyan, N; La, E; Laporte, R; Qi, S; Rehberg, J; Rehberg, S; Rivière, PJ; Schteingart, CD; Traber, DL; Traber, LD; Wisniewski, K | 1 |
Chen, P | 1 |
Guzman, JA; Kruse, JA; Rosado, AE | 1 |
SHUBIN, H; SUDRANN, RB; WEIL, MH | 1 |
ALTURA, BM; HERSHEY, SG; HSU, R; MAZZIA, VD | 1 |
Antunes-Rodrigues, J; Branco, LG; Carnio, EC; de Castro, M; Giusti-Paiva, A | 1 |
Bredle, DL; Klinzing, S; Meier-Hellmann, A; Reinhart, K; Simon, M | 1 |
Bone, HG; Freise, H; Kehrel, BE; Sielenkämper, AW; Van Aken, H; Westphal, M | 1 |
Bone, HG; Westphal, M | 1 |
Dünser, MW; Hasibeder, WR; Mayr, AJ; Wenzel, V | 2 |
Schrier, RW; Wang, W | 1 |
Albert, M; Faivre, V; Hayon, D; Losser, MR; Payen, D | 1 |
Holmes, CL | 1 |
Arendshorst, WJ; Boffa, JJ | 1 |
Duenser, MW; Hasibeder, WR | 1 |
Antunes-Rodrigues, J; Batalhão, ME; Branco, LG; Carnio, EC; Magder, S; Silva, JS; Stabile, AM | 1 |
Schulze, D | 1 |
Dünser, MW; Friesenecker, B; Hasibeder, W; Jochberger, S; Knotzer, H; Luckner, G; Mayr, AJ; Mayr, VD; Pajk, W; Schmid, S; Ulmer, H; Wenzel, V | 1 |
Asfar, P; Hauser, B; Radermacher, P | 1 |
Brandner, J; Dünser, MW; Friesenecker, B; Hasibeder, WR; Hausdorfer, H; Iannetti, C; Knotzer, H; Maier, S; Pajk, W; Torgersen, C; Ulmer, H | 1 |
Baghai, A; Gortner, L; Gottschling, S; Meyer, S; Wurm, D | 1 |
Dünser, MW; Friesenecker, BE; Hasibeder, WR; Jochberger, S; Luckner, G; Mayr, VD; Morgenthaler, NG; Wenzel, V | 1 |
Dünser, MW; Lindner, KH; Wenzel, V | 1 |
Peters, J; Treschan, TA | 1 |
Antunes-Rodrigues, J; Carnio, EC; Moreto, V; Stabile, AM | 1 |
Lee, CS | 1 |
Dünser, MW; Hasibeder, WR; Meier-Hellmann, A; Wenzel, V | 1 |
Bergmann, A; Christ-Crain, M; Morgenthaler, NG; Müller, B; Redl, H; Struck, J | 1 |
Ertmer, C; Lange, M; Westphal, M | 1 |
Inui, D; Nishimura, M; Ohto, J | 1 |
Faivre, V; Kopel, T; Losser, MR; Payen, D | 1 |
Aiura, K; Endo, M; Kitajima, M; Ueda, M | 1 |
Baker, CH; Price, JM; Sutton, ET; Zhou, Z | 1 |
Matsuoka, T; Wisner, DH | 1 |
Banba, N; Emoto, T; Hattori, Y; Kasai, K; Nakamura, T; Sekiguchi, Y; Shimoda, S; Takahashi, K | 1 |
Baker, CH; Dietz, JR; Sutton, ET; Zhou, Z | 1 |
Ashton, D; Dytko, G; Huffman, W; Kinter, LB; McDonald, J; Stassen, F | 1 |
Baver-Neff, BS; Cronenwett, JL; Grekin, RJ; Sheagren, JN | 1 |
Brunner, HR; Nussberger, J; Schaller, MD; Waeber, B | 1 |
20 review(s) available for arginine vasopressin and Endotoxin Shock
Article | Year |
---|---|
Incidence of Hypotension after Discontinuation of Norepinephrine or Arginine Vasopressin in Patients with Septic Shock: a Systematic Review and Meta-Analysis.
Topics: Arginine Vasopressin; Humans; Hypotension; Incidence; Medication Adherence; Norepinephrine; Odds Ratio; Shock, Septic; Vasoconstrictor Agents | 2020 |
Narrative Review of Controversies Involving Vasopressin Use in Septic Shock and Practical Considerations.
Topics: Arginine Vasopressin; Arterial Pressure; Body Weight; Humans; Hypotension; Norepinephrine; Practice Guidelines as Topic; Shock, Septic; Vasoconstrictor Agents | 2020 |
Mortality benefit of vasopressor and inotropic agents in septic shock: a Bayesian network meta-analysis of randomized controlled trials.
Topics: Arginine Vasopressin; Bayes Theorem; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Humans; Norepinephrine; Randomized Controlled Trials as Topic; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2014 |
Vasopressin in cirrhosis and sepsis: physiology and clinical implications.
Topics: Arginine Vasopressin; Humans; Liver Circulation; Liver Cirrhosis; Sepsis; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2015 |
The effect of vasoactive drugs on mortality in patients with severe sepsis and septic shock. A network meta-analysis of randomized trials.
Topics: Arginine Vasopressin; Cardiotonic Agents; Dobutamine; Dopamine; Epinephrine; Humans; Hydrazones; Network Meta-Analysis; Norepinephrine; Odds Ratio; Pyridazines; Randomized Controlled Trials as Topic; Sepsis; Shock, Septic; Simendan; Treatment Outcome; Vasoconstrictor Agents; Vasopressins | 2017 |
Arginine vasopressin in the treatment of vasodilatory septic shock.
Topics: Animals; Arginine Vasopressin; Clinical Trials as Topic; Humans; Shock, Septic; Vasoconstrictor Agents; Vasodilation; Vasopressins | 2008 |
Arginine vasopressin vs. terlipressin in the treatment of shock states.
Topics: Animals; Arginine Vasopressin; Humans; Infusions, Intravenous; Injections, Intravenous; Lypressin; Shock; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2008 |
Best vasopressor for advanced vasodilatory shock: should vasopressin be part of the mix?
Topics: Arginine Vasopressin; Clinical Trials as Topic; Critical Care; Dose-Response Relationship, Drug; Drug Monitoring; Drug Therapy, Combination; Epinephrine; Humans; Norepinephrine; Resuscitation; Shock, Septic; Treatment Outcome; Vasoconstrictor Agents | 2010 |
The stress hormone copeptin: a new prognostic biomarker in acute illness.
Topics: Acute Disease; Adrenocorticotropic Hormone; Arginine Vasopressin; Biomarkers; C-Reactive Protein; Cerebral Infarction; Corticotropin-Releasing Hormone; Glycopeptides; Heart Failure; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Myocardial Infarction; Pituitary-Adrenal System; Pneumonia, Bacterial; Prognosis; Pulmonary Disease, Chronic Obstructive; Sepsis; Shock, Septic; Survival Analysis | 2010 |
Arginine vasopressin for the treatment of septic shock in adults.
Topics: Adrenal Cortex Hormones; Adult; Arginine Vasopressin; Drug Dosage Calculations; Drug Interactions; Hemostatics; Humans; Norepinephrine; Randomized Controlled Trials as Topic; Shock, Septic; Time Factors; Vasoconstrictor Agents | 2010 |
Vasopressin in sepsis and septic shock.
Topics: Adrenal Cortex Hormones; Animals; Arginine Vasopressin; Catecholamines; Drug Administration Routes; Drug Administration Schedule; Drug Evaluation, Preclinical; Drug Interactions; Drug Therapy, Combination; Humans; Hypotension; Ischemia; Lypressin; Molecular Structure; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Receptors, Vasopressin; Sepsis; Shock, Septic; Terlipressin; Vasoconstriction; Vasoconstrictor Agents | 2010 |
Increased complexity of vasopressin's vascular actions.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Disease Models, Animal; Female; Receptors, Vasopressin; Shock, Septic | 2010 |
The role of vasopressin and terlipressin in catecholamine-resistant shock and cardio-circulatory arrest in children: review of the literature.
Topics: Adolescent; Arginine Vasopressin; Cardiac Output, Low; Cardiopulmonary Resuscitation; Catecholamines; Child; Child, Preschool; Drug Resistance; Female; Heart Arrest; Hemodynamics; Hospital Mortality; Humans; Infant; Infant, Newborn; Infant, Premature, Diseases; Lypressin; Male; Randomized Controlled Trials as Topic; Shock, Cardiogenic; Shock, Septic; Survival Rate; Terlipressin; Young Adult | 2011 |
Vasopressin: new uses in critical care.
Topics: Arginine Vasopressin; Guidelines as Topic; Humans; Hypotension; Models, Chemical; Shock, Septic; Tachycardia, Ventricular; Vasoconstrictor Agents; Ventricular Fibrillation | 2002 |
Acute renal failure and sepsis.
Topics: Acute Kidney Injury; Arginine Vasopressin; Hemodynamics; Humans; Nitric Oxide; Sepsis; Shock, Septic; Vasoconstriction; Vasoconstrictor Agents; Vasodilation | 2004 |
Arginine vasopressin in 316 patients with advanced vasodilatory shock.
Topics: Arginine Vasopressin; Blood Pressure; Heart Rate; Humans; Liver; Shock, Septic | 2005 |
The vasopressin system: physiology and clinical strategies.
Topics: Adrenocorticotropic Hormone; Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Blood Pressure; Cardiopulmonary Resuscitation; Hemostasis; Humans; Hypertension; Hypertension, Portal; Neuroendocrine Tumors; Shock, Septic; Vasopressins; Water-Electrolyte Balance | 2006 |
Role of exogenous arginine vasopressin in the management of catecholamine-refractory septic shock.
Topics: Arginine Vasopressin; Blood Pressure; Cardiac Output; Catecholamines; Clinical Trials as Topic; Critical Care; Drug Monitoring; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Practice Guidelines as Topic; Research Design; Shock, Septic; Staphylococcal Infections; Treatment Outcome; Vasoconstrictor Agents | 2006 |
[Arginine-vasopressin in septic and vasodilatorial shock].
Topics: Arginine Vasopressin; Humans; Practice Guidelines as Topic; Practice Patterns, Physicians'; Shock, Cardiogenic; Shock, Septic; Vasoconstrictor Agents | 2006 |
Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.
Topics: Arginine Vasopressin; Humans; Infusions, Intravenous; Lypressin; Metabolic Clearance Rate; Shock, Septic; Terlipressin; Treatment Outcome; Vasoconstrictor Agents | 2008 |
3 trial(s) available for arginine vasopressin and Endotoxin Shock
Article | Year |
---|---|
Role of selective V2-receptor-antagonism in septic shock: a randomized, controlled, experimental study.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Disease Models, Animal; Female; Receptors, Vasopressin; Sheep; Shock, Septic | 2010 |
Effects of vasopressinergic receptor agonists on sublingual microcirculation in norepinephrine-dependent septic shock.
Topics: Adrenergic alpha-Agonists; Aged; Arginine Vasopressin; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Lypressin; Male; Microcirculation; Middle Aged; Mouth Floor; Norepinephrine; Prospective Studies; Receptors, Vasopressin; Shock, Septic; Terlipressin | 2011 |
High-dose vasopressin is not superior to norepinephrine in septic shock.
Topics: Adult; Aged; APACHE; Arginine Vasopressin; Dose-Response Relationship, Drug; Female; Hemodynamics; Humans; Liver Circulation; Male; Middle Aged; Norepinephrine; Renal Agents; Shock, Septic; Vasoconstrictor Agents | 2003 |
69 other study(ies) available for arginine vasopressin and Endotoxin Shock
Article | Year |
---|---|
Role of Tumor Necrosis Factor-α in vascular hyporeactivity following endotoxic shock and its mechanism.
Topics: Animals; Arginine Vasopressin; Calcium; Female; Male; Myosin Light Chains; Phosphorylation; Rabbits; rho-Associated Kinases; Shock, Septic; Tumor Necrosis Factor-alpha; Vasoconstriction | 2019 |
Abrupt Discontinuation Versus Down-Titration of Vasopressin in Patients Recovering from Septic Shock.
Topics: Aged; Arginine Vasopressin; Cohort Studies; Female; Humans; Male; Middle Aged; Retrospective Studies; Shock, Septic; Treatment Outcome; Withholding Treatment | 2021 |
[Investigation of vasopressin response to increasing osmotic pressure in the late-phase of septic shock patients].
Topics: Aged; Aged, 80 and over; APACHE; Arginine Vasopressin; Female; Humans; Male; Middle Aged; Osmotic Pressure; Prospective Studies; Shock, Septic | 2014 |
Early vasopressin reduces incidence of new onset arrhythmias.
Topics: Aged; Arginine Vasopressin; Arrhythmias, Cardiac; Catecholamines; Critical Illness; Drug Administration Schedule; Female; Hospital Mortality; Humans; Incidence; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Shock, Septic; Vasopressins | 2014 |
Beneficial and side effects of arginine vasopressin and terlipressin for septic shock.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Calcium; Dose-Response Relationship, Drug; Female; Lypressin; Male; Norepinephrine; Rabbits; Rats; Rats, Sprague-Dawley; Sex Characteristics; Shock, Septic; Terlipressin | 2015 |
The impact of endocrine supplementation on adverse events in septic shock.
Topics: Adrenal Cortex Hormones; Aged; Arginine Vasopressin; Critical Care; Endocrine System; Female; Hemodynamics; Hospital Mortality; Humans; Hydrocortisone; Incidence; Intensive Care Units; Male; Middle Aged; Norepinephrine; Retrospective Studies; Shock, Septic; Vasopressins | 2015 |
A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock.
Topics: Animals; Arginine Vasopressin; Female; Norepinephrine; Random Allocation; Receptors, Vasopressin; Sheep; Sheep Diseases; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2016 |
Ascorbate-dependent vasopressor synthesis: a rationale for vitamin C administration in severe sepsis and septic shock?
Topics: Arginine Vasopressin; Ascorbic Acid; Hemodynamics; Humans; Norepinephrine; Sepsis; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2015 |
Selepressin in Septic Shock: A Step Toward Decatecholaminization?
Topics: Animals; Arginine Vasopressin; Female; Norepinephrine; Receptors, Vasopressin; Sheep Diseases; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2016 |
Vasopressin, Norepinephrine, and Vasodilatory Shock after Cardiac Surgery: Another "VASST" Difference?
Topics: Arginine Vasopressin; Humans; Norepinephrine; Shock; Shock, Septic; Vasoconstrictor Agents; Vasodilation; Vasopressins | 2017 |
Vasopressin in critical illness: sometimes even old players leave a lot to discover. Preface.
Topics: Arginine Vasopressin; Critical Illness; Humans; Receptors, Vasopressin; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2008 |
Effect of corticosteroids on arginine vasopressin-containing vasopressor therapy for septic shock: a case control study.
Topics: Academic Medical Centers; Aged; APACHE; Arginine Vasopressin; Drug Therapy, Combination; Female; Fludrocortisone; Glucocorticoids; Humans; Hydrocortisone; Intensive Care Units; Male; Middle Aged; Retrospective Studies; Shock, Septic; Vasoconstrictor Agents | 2008 |
Thermoregulation and vasopressin secretion during polymicrobial sepsis.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Body Temperature Regulation; Disease Models, Animal; Disease Progression; Hypotension; Hypothalamus; Laparotomy; Male; Mortality; Nitric Oxide; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Sepsis; Shock, Septic; Supraoptic Nucleus; Up-Regulation | 2009 |
The vasopressin and copeptin response to infection, severe sepsis, and septic shock.
Topics: Adult; Aged; Arginine Vasopressin; Cohort Studies; Female; Glycopeptides; Humans; Infections; Intensive Care Units; Male; Middle Aged; Sepsis; Severity of Illness Index; Shock, Septic | 2009 |
Catecholamines, vasopressin and markers of acute liver injury in septic shock.
Topics: Animals; Arginine Vasopressin; Biomarkers; Catecholamines; Humans; Liver; Liver Failure, Acute; Models, Biological; Perfusion; Resuscitation; Shock, Septic | 2009 |
[Advanced vasodilatory shock. One-year survival after arginine vasopressin therapy].
Topics: Aged; Arginine Vasopressin; Cause of Death; Female; Hospital Mortality; Humans; Intensive Care Units; Male; Middle Aged; Postoperative Complications; Retrospective Studies; Shock, Cardiogenic; Shock, Septic; Survival Analysis; Systemic Inflammatory Response Syndrome; Vasodilation | 2009 |
Vasopressin and its copilot copeptin in sepsis and septic shock.
Topics: Arginine Vasopressin; Clinical Trials as Topic; Glycopeptides; Humans; Sepsis; Shock, Septic; Vasopressins | 2009 |
Role of arginine vasopressin and terlipressin as first-line vasopressor agents in fulminant ovine septic shock.
Topics: Animals; Arginine Vasopressin; Drug Therapy, Combination; Female; Hemodynamics; Lypressin; Random Allocation; Sheep; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
Comment: Terlipressin for children with extremely low cardiac output after open heart surgery.
Topics: Arginine Vasopressin; Cardiac Output, Low; Child; Hemodynamics; Humans; Infant, Newborn; Lypressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2009 |
Comparison of cardiac, hepatic, and renal effects of arginine vasopressin and noradrenaline during porcine fecal peritonitis: a randomized controlled trial.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Feces; Heart; Kidney; Liver; Norepinephrine; Peritonitis; Random Allocation; Shock, Septic; Swine | 2009 |
Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
Topics: Animals; Arginine Vasopressin; Drug-Related Side Effects and Adverse Reactions; Norepinephrine; Shock, Septic; Sus scrofa; Vasoconstrictor Agents | 2009 |
Vasopressin synthesis by the magnocellular neurons is different in the supraoptic nucleus and in the paraventricular nucleus in human and experimental septic shock.
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine Vasopressin; Disease Models, Animal; Female; Humans; Male; Middle Aged; Neurons; Paraventricular Hypothalamic Nucleus; Rats; Rats, Wistar; Shock, Septic; Supraoptic Nucleus | 2010 |
Osmoregulation of vasopressin secretion is altered in the postacute phase of septic shock.
Topics: Adrenocorticotropic Hormone; Aged; Arginine Vasopressin; Blood Pressure; Calcitonin; Female; Humans; Hydrocortisone; Interleukin-10; Interleukin-6; Male; Middle Aged; Prospective Studies; Protein Precursors; Severity of Illness Index; Shock, Septic; Sodium; Water-Electrolyte Balance | 2010 |
Effects of combined arginine vasopressin and levosimendan on organ function in ovine septic shock.
Topics: Animals; Arginine Vasopressin; Blood Gas Analysis; Blood Pressure; Drug Therapy, Combination; Hydrazones; Lung; Myocardial Contraction; Norepinephrine; Pulmonary Wedge Pressure; Pyridazines; Sheep; Shock, Septic; Simendan; Vascular Resistance; Vasoconstrictor Agents; Water-Electrolyte Balance | 2010 |
Disorder of osmoregulation as a new pathogenetic mechanism of septic shock?
Topics: Arginine Vasopressin; Humans; Shock, Septic; Water-Electrolyte Balance | 2010 |
Vasopressin, levosimendan, and cardiovascular function in septic shock.
Topics: Animals; Arginine Vasopressin; Cardiovascular System; Drug Therapy, Combination; Hydrazones; Norepinephrine; Pyridazines; Sheep; Shock, Septic; Simendan; Vasoconstrictor Agents | 2010 |
Role of selective V1a receptor agonism in ovine septic shock.
Topics: Animals; Arginine Vasopressin; Blood Gas Analysis; Disease Models, Animal; Female; Hemodynamics; Immunohistochemistry; Kaplan-Meier Estimate; Norepinephrine; Oxygen Consumption; Pulmonary Gas Exchange; Random Allocation; Receptors, Vasopressin; Reference Values; Sheep; Sheep, Domestic; Shock, Septic; Survival Rate; Vasotocin | 2011 |
Mirror, mirror on the wall: Which is the best vasopressin receptor of them all?
Topics: Animals; Arginine Vasopressin; Blood Pressure; Blood Pressure Determination; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Hemodynamics; Humans; Norepinephrine; Random Allocation; Receptors, Vasopressin; Reference Values; Sheep; Sheep, Domestic; Shock, Septic; Survival Rate; Vasotocin | 2011 |
Vasopressin analogues and V1a receptor agonists in septic shock.
Topics: Arginine Vasopressin; Catecholamines; Clinical Trials as Topic; Humans; Lypressin; Microcirculation; Perfusion; Receptors, Vasopressin; Shock, Septic; Terlipressin; Vasoconstrictor Agents | 2011 |
Influences of hydrocortisone therapy on arginine vasopressin plasma levels in septic shock.
Topics: Aged; Arginine Vasopressin; Humans; Hydrocortisone; Middle Aged; Shock, Septic | 2011 |
Combined arginine vasopressin and levosimendan: a promising therapy for septic shock.
Topics: Animals; Arginine Vasopressin; Drug Therapy, Combination; Humans; Hydrazones; Pyridazines; Sheep; Shock, Septic; Simendan; Vasodilator Agents | 2011 |
Arginine-vasopressin and corticosteroids in septic shock: engaged but not yet married!
Topics: Anti-Inflammatory Agents; Arginine Vasopressin; Female; Hemostatics; Humans; Hydrocortisone; Male; Shock, Septic | 2011 |
Concomitant arginine-vasopressin and hydrocortisone therapy in severe septic shock: association with mortality.
Topics: Aged; Anti-Inflammatory Agents; Arginine Vasopressin; Austria; Cohort Studies; Drug Therapy, Combination; Female; Hemostatics; Humans; Hydrocortisone; Intensive Care Units; Male; Middle Aged; Outcome Assessment, Health Care; Proportional Hazards Models; Retrospective Studies; Shock, Septic | 2011 |
Effects of combined levosimendan and vasopressin on pulmonary function in porcine septic shock.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Drug Therapy, Combination; Female; Hemodynamics; HMG-Box Domains; Hydrazones; Inflammation; Interleukin-6; Lactic Acid; Lung; Nitrates; Nitrites; Norepinephrine; Peritonitis; Pulmonary Artery; Pulmonary Gas Exchange; Pyridazines; Random Allocation; Respiratory Physiological Phenomena; Shock, Septic; Simendan; Swine | 2012 |
Changes in CRH and ACTH synthesis during experimental and human septic shock.
Topics: Adrenocorticotropic Hormone; Animals; Arginine Vasopressin; Corticotropin-Releasing Hormone; Disease Models, Animal; Humans; Immunohistochemistry; In Situ Hybridization; Nitric Oxide Synthase Type II; Rats; Receptors, Vasopressin; RNA, Messenger; Shock, Septic | 2011 |
Predictors of prolonged vasopressin infusion for the treatment of septic shock.
Topics: Adult; Arginine Vasopressin; Cohort Studies; Female; Hemodynamics; Humans; Logistic Models; Male; Multivariate Analysis; Prognosis; Retrospective Studies; Risk Factors; Shock, Septic; Survival Rate; Time Factors; United States; Vasoconstrictor Agents | 2012 |
Unlike arginine vasopressin, the selective V1a receptor agonist FE 202158 does not cause procoagulant effects by releasing von Willebrand factor.
Topics: Animals; Arginine Vasopressin; Blood Coagulation; Female; Prospective Studies; Random Allocation; Receptors, Vasopressin; Sheep; Shock, Septic; Vasopressins; von Willebrand Factor | 2012 |
Vasopressin vs norepinephrine in endotoxic shock: systemic, renal, and splanchnic hemodynamic and oxygen transport effects.
Topics: Animals; Arginine Vasopressin; Biological Availability; Biological Transport; Dogs; Hemodynamics; Injections, Intravenous; Intestinal Mucosa; Norepinephrine; Oxygen; Portal Vein; Regional Blood Flow; Renal Circulation; Resuscitation; Shock, Septic; Splanchnic Circulation; Stroke Volume; Vasoconstrictor Agents | 2003 |
Treatment of endotoxic shock--the dilemma of vasopressor and vasodilator therapy.
Topics: Animals; Antitoxins; Arginine Vasopressin; Arterioles; Blood Pressure; Dogs; Hemodynamics; Shock; Shock, Septic; Toxins, Biological; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents; Vasopressins | 1962 |
INFLUENCE OF VASOPRESSORS ON SURVIVAL AFTER TRAUMATIC, INTESTINAL ISCHEMIA AND ENDOTOXIN SHOCK IN RATS.
Topics: Angiotensins; Arginine Vasopressin; Endotoxins; Felypressin; Intestinal Diseases; Ischemia; Norepinephrine; Pharmacology; Rats; Research; Shock, Septic; Shock, Traumatic; Vasoconstrictor Agents; Vasopressins | 1965 |
Role of nitric oxide in thermoregulation during septic shock: involvement of vasopressin.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Body Temperature; Body Temperature Regulation; Enzyme Inhibitors; Injections, Intraventricular; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Shock, Septic | 2003 |
Arginine vasopressin compromises gut mucosal microcirculation in septic rats.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Infusions, Intravenous; Intestinal Mucosa; Male; Microcirculation; Probability; Random Allocation; Rats; Rats, Sprague-Dawley; Reference Values; Regional Blood Flow; Risk Factors; Sensitivity and Specificity; Shock, Septic | 2004 |
Are vasodilatory shock states due to sepsis and cardiovascular surgery like two peas in a pod?
Topics: Arginine Vasopressin; Cardiac Surgical Procedures; Humans; Postoperative Complications; Shock; Shock, Septic | 2004 |
Lessons learned from high-dosage vasopressin infusion in septic shock.
Topics: Arginine Vasopressin; Hemodynamics; Humans; Shock, Septic | 2004 |
Comment on "Role of vasopressin in the management of septic shock" by Mutlu and Factor.
Topics: Arginine Vasopressin; Blood Circulation; Blood Pressure; Humans; Lypressin; Pulmonary Circulation; Shock, Septic; Vasoconstrictor Agents; Vasopressins | 2004 |
Systemic and renal macro- and microcirculatory responses to arginine vasopressin in endotoxic rabbits.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Blood Flow Velocity; Dose-Response Relationship, Drug; Hemodynamics; Kidney Cortex; Kidney Medulla; Laser-Doppler Flowmetry; Male; Microcirculation; Prospective Studies; Rabbits; Random Allocation; Regression Analysis; Renal Circulation; Shock, Septic; Vasoconstrictor Agents | 2004 |
Is low-dose vasopressin the new reno-protective agent?
Topics: Acute Kidney Injury; Animals; Arginine Vasopressin; Dose-Response Relationship, Drug; Humans; Renal Circulation; Shock, Septic; Vasoconstrictor Agents | 2004 |
Maintenance of renal vascular reactivity contributes to acute renal failure during endotoxemic shock.
Topics: Acute Kidney Injury; Angiotensin II; Animals; Arginine Vasopressin; Enzyme Inhibitors; Glomerular Filtration Rate; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Renal Circulation; Shock, Septic; Urine; Vasoconstrictor Agents | 2005 |
Dear vasopressin, where is your place in septic shock?
Topics: Arginine Vasopressin; Catecholamines; Critical Care; Drug Therapy, Combination; Hemodynamics; Hormone Replacement Therapy; Humans; Norepinephrine; Shock, Septic; Vasoconstrictor Agents | 2005 |
Vasopressin release during endotoxaemic shock in mice lacking inducible nitric oxide synthase.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Female; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nitric Oxide; Nitric Oxide Synthase Type II; Shock, Septic | 2005 |
[Pathogenesis and therapeutic strategy].
Topics: Acute Kidney Injury; Animals; Arginine Vasopressin; Glucocorticoids; Humans; Hyperglycemia; Nitric Oxide; Nitric Oxide Synthase; Rats; Renal Agents; Renal Dialysis; Sepsis; Shock, Septic | 2005 |
Vasopressin and splanchnic blood flow: vasoconstriction does not equal vasoconstriction in every organ.
Topics: Animals; Arginine Vasopressin; Dose-Response Relationship, Drug; Humans; Jejunum; Microcirculation; Oxygen; Shock, Septic; Splanchnic Circulation; Swine; Vasoconstrictor Agents | 2006 |
Arginine vasopressin does not alter mucosal tissue oxygen tension and oxygen supply in an acute endotoxemic pig model.
Topics: Analysis of Variance; Animals; Arginine Vasopressin; Dose-Response Relationship, Drug; Intestinal Mucosa; Jejunum; Microcirculation; Oxygen; Partial Pressure; Random Allocation; Shock, Septic; Spectrophotometry; Splanchnic Circulation; Swine; Vasoconstrictor Agents | 2006 |
Arginine-vasopressin in catecholamine-refractory septic versus non-septic shock in extremely low birth weight infants with acute renal injury.
Topics: Acute Kidney Injury; Arginine Vasopressin; Blood Pressure; Catecholamines; Female; Humans; Infant, Newborn; Infant, Very Low Birth Weight; Male; Prospective Studies; Shock, Septic | 2006 |
Course of vasopressin and copeptin plasma concentrations in a patient with severe septic shock.
Topics: Arginine Vasopressin; Chronic Disease; Critical Care; Glycopeptides; Hemodynamics; Humans; Hypertension; Intestinal Perforation; Male; Middle Aged; Peritonitis; Shock, Septic; Streptococcal Infections; Streptococcus milleri Group | 2006 |
A century of arginine vasopressin research leading to new therapeutic strategies.
Topics: Arginine Vasopressin; Clinical Trials as Topic; Heart Arrest; Humans; Shock, Hemorrhagic; Shock, Septic | 2006 |
Role of heme-oxygenase pathway on vasopressin deficiency during endotoxemic shock-like conditions.
Topics: Animals; Arginine Vasopressin; Blood Pressure; Deuteroporphyrins; Diuresis; Enzyme Inhibitors; Heart Rate; Heme Oxygenase (Decyclizing); Hypotension; Lipopolysaccharides; Male; Rats; Rats, Wistar; Shock, Septic; Vasopressins | 2006 |
Copeptin, a stable peptide of the arginine vasopressin precursor, is elevated in hemorrhagic and septic shock.
Topics: Adult; Aged; Aged, 80 and over; Animals; Arginine Vasopressin; Disease Models, Animal; Female; Glycopeptides; Humans; Male; Middle Aged; Papio ursinus; Protein Precursors; Retrospective Studies; Shock, Hemorrhagic; Shock, Septic | 2007 |
Massive melena due to arginine-vasopressin for septic shock in two pediatric patients.
Topics: Adolescent; Arginine Vasopressin; Child, Preschool; Female; Humans; Infusions, Intravenous; Leukemia, Myeloid; Male; Melena; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Shock, Septic; Vasoconstrictor Agents | 2008 |
Systemic and hepatosplanchnic macro- and microcirculatory dose response to arginine vasopressin in endotoxic rabbits.
Topics: Animals; Arginine Vasopressin; Disease Models, Animal; Hemodynamics; Hypotension; Intestines; Liver; Microcirculation; Rabbits; Shock, Septic; Splanchnic Circulation; Vasoconstrictor Agents | 2008 |
Lack of an effect of body mass on the hemodynamic response to arginine vasopressin during septic shock.
Topics: Aged; Arginine Vasopressin; Body Mass Index; Creatinine; Female; Hemodynamics; Humans; Male; Middle Aged; Shock, Septic; Vasoconstrictor Agents | 2008 |
Circulating concentrations and physiologic role of atrial natriuretic peptide during endotoxic shock in the rat.
Topics: Aldosterone; Animals; Arginine Vasopressin; Atrial Natriuretic Factor; Diuresis; Hematocrit; Immune Sera; Lipopolysaccharides; Male; Natriuresis; Prospective Studies; Rats; Rats, Wistar; Shock, Septic | 1995 |
In vitro femoral arterial responses to vasoconstrictor and vasodilator agents in endotoxin shock.
Topics: Acetylcholine; Animals; Arginine; Arginine Vasopressin; Bradykinin; Femoral Artery; In Vitro Techniques; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Phenylephrine; Potassium Chloride; Rats; Rats, Wistar; Shock, Septic; Vasoconstrictor Agents; Vasodilator Agents | 1994 |
Hemodynamic and metabolic effects of vasopressin blockade in endotoxin shock.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Endotoxins; Hemodynamics; Hormone Antagonists; Ketone Bodies; Male; Mononuclear Phagocyte System; Oxygen Consumption; Rats; Rats, Sprague-Dawley; Shock, Septic; Vasopressins | 1997 |
Elevation of plasma endothelin concentrations during endotoxin shock in dogs.
Topics: Adrenocorticotropic Hormone; Aldosterone; Animals; Arginine Vasopressin; Cattle; Cells, Cultured; Dogs; Endothelins; Endothelium, Vascular; Female; Hemodynamics; Hydrocortisone; Male; Renin; Shock, Septic | 1991 |
Microvascular vasopressin effects during endotoxin shock in the rat.
Topics: Animals; Arginine Vasopressin; Blood Flow Velocity; Blood Pressure; Endotoxins; Escherichia coli; Male; Microcirculation; Rats; Rats, Inbred Strains; Shock, Septic; Vasoconstriction | 1990 |
Discovery and therapeutic utility of vasopressin antagonists in rats.
Topics: Animals; Arginine Vasopressin; Dehydration; Diuresis; Dose-Response Relationship, Drug; Inappropriate ADH Syndrome; Male; Osmolar Concentration; Rats; Shock, Septic; Vasopressins | 1986 |
The role of endorphins and vasopressin in canine endotoxin shock.
Topics: Animals; Arginine Vasopressin; beta-Endorphin; Blood Pressure; Cardiac Output; Cardiovascular Diseases; Dogs; Endorphins; Endotoxins; Escherichia coli; Female; Heart Rate; Hydrocortisone; Kinetics; Male; Naloxone; Shock, Septic | 1986 |
Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia.
Topics: Angiotensin II; Animals; Arginine Vasopressin; Blood Pressure; Captopril; Endotoxins; Epinephrine; Male; Norepinephrine; Pentobarbital; Prazosin; Rats; Rats, Inbred Strains; Renin; Shock, Septic; Sympathetic Nervous System; Vasopressins | 1985 |